Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: J Vasc Interv Radiol. 2013 Dec 6;25(3):397–404. doi: 10.1016/j.jvir.2013.10.022

Figure 7.

Figure 7

Localized intra-tumoral delivery. Isolated AMF (without MP injection) and procedural exposure did not significantly influence tumor or NHP [Fe] nor tumor:NHP ratios as measured by ICP-OES. Direct injection of IO-YAS MPs with magnetic targeting under direct vision yielded a mean tumor:NHP Fe ratio of 75.2 versus 0.77 in the AMF control group (P < 0.05).